Cholangiocarcinoma survival system

Empathy
We are you. You fight to win — so do we, with you. That is our culture.

Focus
We strip Cholangio of its complexity. Expose its weakness. Strengthen patient response. Accelerate science.

Lead
From the battlefield: strategic calm at the frontline, clarity in the boardrooms that support our fight.

How We Win
Outpace it — put our collective lived expertise to work. Today. Every day.

Nature, to be commanded, must first be obeyed. — Francis Bacon

So it is with cholangiocarcinoma.
To beat it, we must first understand it.

Breaking down the name:

Chol → bile
Angio → vessel or duct
Carcinoma → cancer of the inner lining cells
Cholangiocarcinoma = Cancer of the bile ducts.

Cholangiocarcinoma is a cancer of the bile ducts — an aggressive cancer that begins in the liver’s bile system and can spread quickly to other organs.

Once a cancer of the retired.
Now rising fast — striking younger lives.

Three primary locations
–  Intrahepatic (iCCA) → Found inside the liver within the smaller bile ducts.

– Perihilar / Hilar (pCCA) → Located at the hilum, where the right and left bile ducts exit the liver and join.

– Distal (dCCA) → Found in the common bile duct closer to the pancreas and small intestine (often at or through the pancreatic head).

What’s been missing?
Clear systems. And a real understanding of this cancer’s presence.
– Prevention.
– Early detection.
– A survival model patients can understand and act on.

Currently, the only system is for doctors to manage a patient’s decline.

Patients need more than care alone.
They need empowerment — and the lived expertise that turns experience into survival.

The only way forward is to innovate.
Upstream — prevention: detect bile toxicity before tumours form.
Downstream — survival: build the model and culture to outpace it.

Together — we are all responsible, all accountable.

Learn how you can get involved Light Australia Green initiative.

According to Cancer Australia, incidence of bile duct cancer is rising.